
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
VDUP1 CRISPR/Cas9 KO Plasmid (h) | sc-400664 | 20 µg | $397.00 |
Thioredoxin interacting protein (TXNIP), also known as VDUP1, is a redox-sensitive regulator that binds thioredoxin to modulate cellular oxidative stress responses and redox homeostasis. TXNIP links nutrient and stress signaling to metabolic control by influencing glucose uptake, mitochondrial function, and inflammatory outputs, and it participates in pathways such as AMPK signaling, ROS handling, and NLRP3 inflammasome-associated processes. Altered TXNIP/VDUP1 expression has been associated with metabolic dysregulation, endothelial dysfunction, and inflammatory states, and it is frequently studied in contexts of diabetes-related complications, cardiovascular biology, and cancer cell metabolism. As a stress-inducible gene, TXNIP is also used as a readout and driver of transcriptional programs downstream of ER stress and oxidative signaling.
VDUP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TXNIP gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TXNIP together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TXNIP open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish VDUP1 protein expression.
This CRISPR knockout system enables efficient generation of TXNIP-deficient cell models for investigation of VDUP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.